# Drug Safety & QC Evidence Mapping Foundation

## Biotech Learnship – Test 1

## Project Overview

This project is a beginner-level research and technical foundation for organizing **drug-safety, pharmacovigilance, laboratory quality-control (QC), and evidence-validation information**.

The project demonstrates how a safety-related observation can be structured and reviewed through the following workflow:

```text
Drug/Product
        ↓
Safety Observation
        ↓
Evidence Record
        ↓
Data Validation
        ↓
Signal Detection
        ↓
Evidence Review
        ↓
QC/Laboratory Evidence
        ↓
Scientific Assessment
        ↓
Human Review
        ↓
Documentation
        ↓
Follow-up
```

This project is intended as a reusable foundation that future pharmacy, AI/Data Science, software, laboratory, and QA/QC teams can build upon.

---

# Project Objectives

The main objectives of this project are to:

1. Understand basic pharmacovigilance concepts.
2. Understand the difference between adverse events and adverse drug reactions.
3. Understand how drug-safety signals are identified and validated.
4. Study laboratory QC principles relevant to drug-safety evidence.
5. Organize evidence using structured records.
6. Demonstrate evidence validation and traceability.
7. Research credible public drug-safety and pharmaceutical-quality information sources.
8. Build a simple Python-based Drug Safety Evidence Tracker.
9. Test the system using normal, invalid-input, and evidence-validation cases.
10. Create documentation that allows another researcher to understand and continue the project.

---

# Important Scientific Principles

This project follows the following important distinctions:

```text
Reported Adverse Event
≠
Confirmed Adverse Drug Reaction
```

An adverse event may occur after drug use without being proven to have been caused by the drug.

```text
Safety Signal
≠
Proof of Causality
```

A safety signal is information that may require further investigation. It does not independently prove that a medicine caused an event.

```text
Human Review Flag
≠
Clinical Conclusion
```

A record flagged by the system requires further review and is not an automatic clinical or scientific conclusion.

---

# Project Scope

The project focuses specifically on:

- Pharmacovigilance.
- Drug safety.
- Adverse events.
- Adverse drug reactions.
- Safety signals.
- Signal detection.
- Signal validation.
- Evidence validation.
- Post-marketing surveillance.
- Medication-error reporting.
- Drug-quality complaints.
- Pharmaceutical quality control.
- Laboratory QC.
- Batch/lot traceability.
- Data integrity.
- Evidence provenance.
- Structured evidence records.
- Human-review requirements.

---

# Non-Goals

This project does **not**:

- Diagnose patients.
- Recommend treatment.
- Make clinical decisions.
- Establish drug-event causality automatically.
- Invent medical or regulatory thresholds.
- Replace pharmacovigilance professionals.
- Replace laboratory QC investigations.
- Perform laboratory experiments.
- Use identifiable patient information.

---

# Project Workflow

The overall evidence workflow is:

```text
Observation
→ Report/Evidence Record
→ Data Validation
→ Signal Detection
→ Evidence Review
→ QC/Laboratory Evidence
→ Scientific Assessment
→ Human Review
→ Documentation
→ Follow-up
```

The purpose of this workflow is to demonstrate how safety-related information can be organized before further scientific assessment.

---

# Python Mini-Build

The project includes a simple Python-based program:

```text
drug_safety_tracker.py
```

The Drug Safety Evidence Tracker is designed to:

1. Load a CSV evidence file.
2. Search evidence by drug/product.
3. Filter evidence by evidence type.
4. Filter evidence by validation status.
5. Display safety observations.
6. Display evidence provenance.
7. Flag records requiring human review.
8. Produce structured JSON output.

The program is a learning prototype and should not be considered a clinical decision-making system.

---

# Requirements

To run this project, you need:

- Python 3 installed on your computer.
- A command-line terminal such as PowerShell or Command Prompt.
- The project files.

No advanced programming experience is required to understand the basic purpose of the project.

---

# How to Run the Program

## Step 1: Open the project folder

Open PowerShell or the VS Code terminal inside the project folder.

Example:

```text
Drug_Safety_QC_Evidence_Map
```

## Step 2: Run the Python program

Use the following command:

```bash
python drug_safety_tracker.py --file sample_data/evidence_records.csv --drug "Drug A"
```

The program will load the sample evidence dataset and search for the selected drug/product.

---

# Example Program Output

An example of the type of output produced is:

```text
Drug searched: Drug A

Evidence found: 5
Validated: 3
Needs Review: 2
Safety Signals: 2

Evidence sources:
- FAERS
- PubMed
- Laboratory QC
```

The exact results depend on the sample data and selected search/filter conditions.

The program may also generate structured JSON output for future AI/Data Science processing.

---

# Sample Dataset

The project uses a fictional sample dataset located at:

```text
sample_data/evidence_records.csv
```

The dataset is used only to demonstrate how evidence can be structured and validated.

Important:

- The data is fictional/sample data.
- No identifiable patient information is included.
- The records are not clinical conclusions.
- The dataset is not intended for real patient-care decisions.

---

# Testing

Testing information is documented in:

```text
tests/test_results.md
```

The project includes testing for:

## Normal Test Cases

- Loading a valid CSV file.
- Searching for an existing drug/product.
- Filtering by evidence type.
- Filtering by validation status.
- Producing structured JSON output.

## Invalid-Input Test Cases

- Missing drug name.
- Unknown drug/product.
- Missing or incorrect CSV file path.

## Evidence-Validation Edge Cases

- Incomplete evidence record.
- Invalid validation status.
- Duplicate Evidence ID.
- Conflicting evidence.
- Empty dataset.

The testing demonstrates program behaviour only.

```text
Successful Software Test
≠
Proven Drug-Event Causality
```

---

# Documentation

The repository contains the following documentation.

## README.md

Provides an overview of the project, installation, execution, structure, and usage instructions.

## RESEARCH_REPORT.md

Contains the research foundation for pharmacovigilance, drug safety, adverse events, adverse drug reactions, safety signals, laboratory QC, and evidence validation.

## DATA_SOURCE_REGISTRY.md

Documents credible drug-safety and pharmaceutical-quality information sources, including their purpose, accessibility, evidence quality, limitations, terminology, and potential AI/Data Science use.

## QC_EVIDENCE_MAP.md

Explains how laboratory QC information supports drug-safety evidence and describes the QC evidence workflow.

## EVIDENCE_VALIDATION_MODEL.md

Describes the structured evidence-validation model and sample evidence records.

## LEARNING_NOTES.md

Contains key concepts and learning notes developed during the project.

## REVIEW_PACKET.md

Provides a structured handover summary containing the project entry point, execution flow, testing, limitations, and recommended future work.

## tests/test_results.md

Documents normal tests, invalid-input tests, and evidence-validation edge cases.

---

# Project Structure

```text
Drug-Safety-QC-Evidence-Map/
│
├── drug_safety_tracker.py
├── README.md
├── RESEARCH_REPORT.md
├── DATA_SOURCE_REGISTRY.md
├── QC_EVIDENCE_MAP.md
├── EVIDENCE_VALIDATION_MODEL.md
├── LEARNING_NOTES.md
├── REVIEW_PACKET.md
│
├── sample_data/
│   └── evidence_records.csv
│
├── tests/
│   └── test_results.md
│
└── screenshots/
    ├── 01_successful_execution.png
    ├── 02_filtering_result.png
    ├── 03_json_output.png
    ├── 04_unknown_drug.png
    └── 05_file_error.png
```

---

# Evidence Validation Categories

The project demonstrates the following simplified evidence categories:

- **Validated** – The evidence record has passed the required project-level checks.
- **Incomplete** – Important information is missing.
- **Unverified** – The evidence has not yet been sufficiently checked.
- **Conflicting** – The available evidence contains information that cannot currently be reconciled.
- **Needs Review** – Further human scientific or technical review is required.

These categories are part of the project's learning model and do not replace formal regulatory or clinical classifications.

---

# Public Information Sources Studied

The project research includes examples of credible sources such as:

- FDA FAERS.
- OpenFDA.
- DailyMed.
- FDA Drug Safety Communications.
- WHO pharmacovigilance resources.
- PubMed.
- ClinicalTrials.gov.
- EMA safety information.
- ICH guidelines.

These sources do not all provide the same type or quality of evidence.

The project therefore considers:

```text
Source
+
Evidence Type
+
Data Quality
+
Validation
+
Limitations
+
Human Review
```

rather than treating all public information sources as equally authoritative.

---

# Laboratory QC Component

The laboratory QC component covers:

- Sample identification.
- Sample integrity.
- Instrument calibration.
- Reference standards.
- Controls.
- Replicates.
- Measurement uncertainty.
- Out-of-specification results.
- Out-of-trend results.
- Deviations.
- Equipment maintenance.
- Data integrity.
- Audit trails.
- Result approval and review.
- Batch/lot traceability.

Where a laboratory acceptance limit would be required, the applicable validated analytical method, specification, or regulatory standard should define that limit.

The project does not invent regulatory acceptance criteria.

---

# Data Integrity and Evidence Provenance

## Data Integrity

Data integrity means ensuring that recorded information remains accurate, complete, reliable, and trustworthy throughout its lifecycle.

The project emphasizes that evidence records should be protected from:

- Unexplained changes.
- Missing information.
- Incorrect identification.
- Duplicate records.
- Loss of traceability.

## Evidence Provenance

Evidence provenance means maintaining information about where evidence came from and how it entered the system.

Examples include:

- Original source.
- Source type.
- Date.
- Supporting documentation.
- Drug/product identifier.
- Batch/lot information where applicable.
- Validation status.
- Review status.

Evidence provenance helps future researchers understand and verify the origin of information.

---

# Known Limitations

This project is a beginner-level prototype and has several limitations:

- The sample dataset is fictional.
- No live regulatory database is directly connected to the program.
- The program does not perform formal statistical signal detection.
- The program does not prove causality.
- The program does not diagnose patients.
- The program does not recommend treatment.
- The program does not make clinical decisions.
- The validation logic is simplified for learning purposes.
- Automated checks cannot replace scientific judgement.
- Human pharmacovigilance, laboratory, QA/QC, and other appropriate expert review remains necessary.

---

# Screenshots

The `screenshots/` folder contains evidence of selected program functions and testing, including:

- Successful program execution.
- Filtering/search results.
- Structured JSON output.
- Unknown drug handling.
- File error handling.

These screenshots demonstrate the basic operation of the prototype.

---

# Future Improvements

Future versions of the project could include:

## Data Improvements

- Additional evidence fields.
- Improved duplicate detection.
- Evidence version tracking.
- More standardized terminology.
- Improved missing-data validation.

## Pharmacovigilance Improvements

- More advanced signal-detection methods.
- Literature evidence integration.
- Source-specific validation rules.
- Structured support for causality assessment.

## QC Improvements

- Detailed batch/lot traceability.
- Equipment calibration records.
- OOS/OOT investigation support.
- Audit-trail features.

## AI/Data Science Improvements

- Integration with permitted public structured data sources.
- API-based data retrieval.
- Data-cleaning pipelines.
- Terminology normalization.
- Transparent evidence-quality scoring.
- Data visualization and dashboards.

## Software Improvements

- Graphical user interface.
- Database storage.
- User authentication.
- Role-based review.
- Audit logging.
- Automated testing.
- Improved error handling.

---

# Final Principle

The central principle of this project is:

```text
Structured Evidence
+
Data Integrity
+
Evidence Provenance
+
Automated Checks
+
Human Oversight
```

However:

```text
Structured Evidence
+
Automated Checks
≠
Automatic Scientific or Clinical Truth
```

Scientific interpretation, appropriate validation, traceability, and human review remain essential.

---

# Author

**Shravani Jambhulkar**  
Fourth-Year B.Pharmacy Student

Project Area:

**Pharmacovigilance | Drug Safety | Laboratory QC | Evidence Validation**